Instruments | Categories | Variables |
---|---|---|
Baseline questionnaire | Demographic characteristics | Age; Sex; Nationality; Education; Occupation; Marriage; Family income of last year; Health insurance, etc. |
 | Family history | Liver, renal and other disease history of family members. |
 | Medical history and concurrent disease | Previous hepatitis history; Previous hepatitis virus tests results. Diagnosis and duration of past renal, visional, auditive and other chronic disease history; Allergic history; Concurrent chronic diseases. |
 | TB diagnosis and previous treatment | Definitive diagnosis of TB; Diagnosis time; Diagnosis agency; Anti-TB treatment history; Anti-tuberculosis induced ADEs occurrence history. |
 | Current drug usage information | Product name; Production NO; Dose; Method and cost of anti-tuberculosis drugs and other concurrent using drugs. |
Physical, laboratory examination | Physical examinations | Height; Weight. |
 | Blood routine test | Erythrocyte count (1012/L); Leukocyte count (109/L); Hemoglobin concentration (g/L); Platelet count (109/L). |
 | Urine routine test | PH value; Urine protein; Erythrocyte count; Leukocyte count; Urinary cylinder count. |
 | Liver and renal function test | Alanine aminotransferase (ALT, U/L); Aspartate aminotransferase (AST, U/L); Total bilirubin (TBIL, μmol/L); Blood urea nitrogen (BUN, mmol/L). |
 | Hepatitis B virus marker | HBsAg test. |
Medication record | Anti-TB drugs | Name, commercial name, manufacturer, production number, usage, dosage, starting and ending time of anti-TB drugs, including RHZES and other supplementary anti-TB drugs. |
 | Liver protective drugs | Name, commercial name, manufacturer, production number, usage, dosage, starting and ending time of drugs used for preventing ATLI. |
 | Other drugs | Name, commercial name, manufacturer, production number, usage, dosage, starting and ending time of other drugs used during the anti-TB therapy, for example, antihypertensive drugs, hypoglycaemic drugs, etc. |